iShares MSCI Canada (TSX) vs Sanofi SA — how do they compare? iShares MSCI Canada (TSX) trades at $61.51, while Sanofi SA trades at $43.56 (market cap $104.30B). The key difference: Sanofi SA pays a 5.55% dividend while iShares MSCI Canada (TSX) pays none, and iShares MSCI Canada (TSX) is trading nearer its 52-week high, Sanofi SA nearer its low. Which is the better fit depends on your goals.
| EWC | SNY | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $61.51 | $52.34 |
52-Week Low | $47.00 | $41.33 |
Market Cap | — | $104.30B |
Enterprise Value | — | $124.19B |
Dividend Yield | — | 5.55% |
Trailing returns across standard periods
Latest headlines on both assets
EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.
Read more on EWC →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →